onasemnogen abeparvovec
UkraineMedications containing this active substance
-
Zolgensma
Form: suspension, for intravenous infusion
Active substance Dosage onasemnogen abeparvovec 2 x 10^13 vg/ml ATC: M09AX09
Manufacturer: Novartis Gene Therapies, Inc. (manufacturing, primary packaging, partial quality control, secondary packaging, batch release)